Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21050673

Int. J. Radiat. Oncol. Biol. Phys. 2011 Jun 1 80 2 437-44

Download in:

View as

General Info

PMID
21050673